Analysis for ELV

📈 Growth & Financial Trajectory

From the earliest quarter in data (Q2 2024) to Q1 2026, Revenue rose from $43.886B to $50.181B, about a 14% gain. Net Income declined from $2.301B to $1.760B over the period (~-24%), indicating earnings volatility despite top-line growth. The 8-quarter window shows persistent Gross Margin around the high 80s/low 90s, averaging roughly 89%, with Operating Income in the $1.0–2.5B range on Revenue of about $43–50B, signaling modest operating leverage.

💰 Margins & Cash Flow

Gross Profit Margin remains near 89% across quarters. Operating Expenses are substantial, yielding Operating Income near several billions and a mid-single-digit operating margin. Net Cash Flow From Operating Activities stayed positive through all quarters, peaking at about $4.33B in Q1 2026, with other quarters ranging from a few hundred million to around $1.0–1.5B. Net Cash Flow overall was positive in most quarters; investing cash flows were largely negative, while financing activity varied.

🛡️ Balance Sheet & Liquidity

Current Assets hover around $63–67B and Current Liabilities around $41–45B, implying a credible liquidity cushion (approx. 1.5x current ratio). Long-term Debt sits near $31–32B and Total Liabilities near $75–82B, with Equity in the low-to-mid $40B range, indicating solid capital structure albeit a debt load compatible with cash generation.

⚠️ Key Drivers & Risks

• Drivers: robust managed-care demand; efficiency gains from scale and data/analytics.
• Risks: regulatory/benefit design changes affecting margins; earnings volatility tied to claims experience and tax adjustments.